Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
Data subsets to be shared today in plenary oral presentations at the 2023 Society for Neuro-Oncology Annual MeetingBRISBANE, Calif., Nov....
Month: November 2023
Mendus Announces Nomination Committee for the 2024 Annual General Meeting
Press Release Stockholm, Sweden, November 17, 2023 Mendus AB (publ: IMMU.ST) announced today that the members of the Nomination Committee...
First Product Incorporating Arecor’s Arestat Technology, At220, Launched in Europe
Arecor Therapeutics plc(“Arecor” or the “Group”) FIRST PRODUCT INCORPORATING ARECOR’S ARESTAT TECHNOLOGY, AT220, LAUNCHED IN EUROPE First commercial sale triggers...
Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award
LONDON and RALEIGH, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”),...
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023 aXess demonstrated exceptional patency rates...
Polaris Group Initiates Rolling Submission of Biologic License Application (BLA) for ADI-PEG 20 with U.S. FDA to Treat Malignant Pleural Mesothelioma
TAIPEI, Taiwan and SAN DIGEO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Polaris Group (The Company, TWSE:6550), today announced that the...
Precipio Announces Q3-2023 Shareholder Update Call
Conference Call to be held on November 20th, 2023 at 5:00 PM ESTNEW HAVEN, Conn., Nov. 16, 2023 (GLOBE NEWSWIRE)...
Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- Treated the first patient with advanced inoperable pancreatic cancer at Hadassah Medical Center in Israel in September, alongside safety...
Canadian dentists to government: Here’s how to build a strong dental care plan
TORONTO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- In just a few weeks, the federal government is expected to announce the...
GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
GENFIT highlighted new focus and development strategy in Acute On-Chronic Liver Failure (ACLF)ACLF is a very serious condition affecting ~294,0001...
Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers
Myriad expands pharma service offering by introducing Personalis’ ImmunoID NeXT® platform to its pharmaceutical partners who use MyRisk® Hereditary Cancer...
UpHealth Enters into Definitive Agreement for Sale of Cloudbreak Health Business to GTCR for $180 Million
Proceeds Will be Utilized to Pay Down All Unsecured Debt and Approximately 45% of Secured Debt UpHealth Will Focus on...
Accolade Announces Repurchase of $76.5 Million of 0.50% Convertible Senior Notes Due 2026
SEATTLE, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it has entered into separate, privately...
iZafe Group’s Quarterly Report Q3, July-September 2023
STOCKHOLM, SWEDEN / ACCESSWIRE / November 17, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) today presents its report...
Khiron Life Sciences Announces Update to the Proposed Sale of Its European Business
Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTC Pink: KHRNF) ("Khiron" or the...
Protagonist Therapeutics Reports Granting of Inducement Awards
NEWARK, CA / ACCESSWIRE / November 16, 2023 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on November 15, 2023,...
NextGen Healthcare Value-Based Care Solutions Help Unlock $82 Million in Medicare Savings
Innovative Data Analytics Solution Enables Healthcare Organizations to Better Serve Medicare ACO BeneficiariesREMOTE-FIRST COMPANY/WICHITA, Kan.--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, Inc. a leading...
IMPLANET Receives the Approval of Its Shareholders for Its Planned Capital Increase
Adoption of resolutions at today's Extraordinary General Meeting concerning the capital increase to take place in January 2024 BORDEAUX, France...
Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
SAN DIEGO, CA / ACCESSWIRE / November 16, 2023 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a clinical-stage...
NCQA Launches Virtual Care Accreditation Pilot Program
18 pioneering organizations to help NCQA create roadmap for high-quality virtual careWASHINGTON, DC / ACCESSWIRE / November 16, 2023 /...